CXCR4 and familial pancreatic carcinoma: Both JunB and CXCR4 have been shown to be overexpressed breast cancer (Kallergi et al., 2019, 2020), and CXCR4 has been implicated in tumor progression in pancreatic cancer (Dubrovska et al., 2012).